What is the optimal dosage of mesalazine to maintain remission in patients with ulcerative colitis?

Affiliations

Comment

Simon Travis. Nat Clin Pract Gastroenterol Hepatol. 2005 Dec.

. 2005 Dec;2(12):564-5.

doi: 10.1038/ncpgasthep0336.

¹ Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK. simon.travis@orh.nhs.uk

No abstract available

Comment on

Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.
Paoluzi OA, Iacopini F, Pica R, Crispino P, Marcheggiano A, Consolazio A, Rivera M, Paoluzi P. Paoluzi OA, et al. Aliment Pharmacol Ther. 2005 May 1;21(9):1111-9. doi: 10.1111/j.1365-2036.2005.02458.x. Aliment Pharmacol Ther. 2005. PMID: 15854173 Clinical Trial.